Literature DB >> 7028987

Sera from patients with systemic lupus erythematosus reactive with human endothelial cells.

M Shingu, E R Hurd.   

Abstract

Human endothelial cells (EC) cultured from umbilical cord veins were reacted with sera from patients with systemic lupus erythematous (SLE), rheumatoid arthritis (RA) and normal persons. Immunofluorescent staining for IgG, IgM and IgA was then performed. Two types of control cells were also used, human foreskin fibroblasts and KB cells (a human carcinoma cell line). Sera from 9 of the 18 (50%) SLE patients showed cytoplasmic staining of EC for IgG. KB cells and fibroblasts did not stain. None of the RA or normal sera showed positive staining. In the 9 instances in which there was positive staining, 4 had evidence of cutaneous vasculitis. In contrast, none of the 9 patients without EC cytoplasmic staining had clinical evidence of cutaneous vasculitis. This data suggests that some SLE patients have an IgG antibody that reacts with EC cytoplasm which may be related to cutaneous vasculitis.

Entities:  

Mesh:

Year:  1981        PMID: 7028987

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  9 in total

Review 1.  Antiendothelial cell antibodies (AECA) in systemic lupus erythematosus (SLE).

Authors:  D D'Cruz; M Khamashta; G Hughes
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

2.  IgG and IgM anti-endothelial cell antibodies in patients with collagen-vascular disorders.

Authors:  N P Quadros; P J Roberts-Thomson; A S Gallus
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

3.  Prevalence of anti-endothelial cell antibodies in patients with autoimmune diseases.

Authors:  E Nylander Lundqvist; O Back; T K Nilsson; S Rantapaa-Dahlqvist
Journal:  Clin Rheumatol       Date:  1992-06       Impact factor: 2.980

4.  Anti-endothelial cell antibodies in patients with rheumatoid arthritis complicated by vasculitis.

Authors:  A H Heurkens; P S Hiemstra; G J Lafeber; M R Daha; F C Breedveld
Journal:  Clin Exp Immunol       Date:  1989-10       Impact factor: 4.330

5.  Characterization of autoantibodies to endothelial cells in systemic sclerosis (SSc): association with pulmonary fibrosis.

Authors:  H Ihn; S Sato; M Fujimoto; A Igarashi; N Yazawa; M Kubo; K Kikuchi; K Takehara; K Tamaki
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

6.  Serum immunoglobulin G reactive with endothelial cells in inflammatory bowel disease.

Authors:  A M Sawyerr; B E Pottinger; C O Savage; N J Bradley; M Hudson; A J Wakefield; J D Pearson; R E Pounder
Journal:  Dig Dis Sci       Date:  1994-09       Impact factor: 3.199

7.  Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus.

Authors:  D B Cines; A P Lyss; M Reeber; M Bina; R J DeHoratius
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

8.  Antibodies to endothelial cells in systemic lupus erythematosus: a potential marker for nephritis and vasculitis.

Authors:  D P D'Cruz; F A Houssiau; G Ramirez; E Baguley; J McCutcheon; J Vianna; H J Haga; G T Swana; M A Khamashta; J C Taylor
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

9.  Relationship between anti-cardiolipin and anti-endothelial cell antibodies in systemic lupus erythematosus.

Authors:  A Vismara; P L Meroni; A Tincani; E N Harris; W Barcellini; A Brucato; M Khamashta; G R Hughes; C Zanussi; G Balestrieri
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.